Concepedia

Juan A. Bueren‐Calabuig

JA

15

Publications

759

Citations

13

H-Index

2009

Active since

Affiliations

University of Dundee(Current)

Universidad de Alcalá

Wellcome Centre for Anti-Infectives Research

PharmaMar (Spain)

GlaxoSmithKline (Spain)

Juan A. Bueren‐Calabuig is an author at University of Dundee specializing in molecular biology, natural sciences, and medicine.

ORCID

Top concepts

Publications per year

2009–2020

15

Publications

15

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 165 citations · Full text

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis

Beatriz Baragaña, Barbara Forte, Ryan Choi et al. · Proceedings of the National Academy of Sciences · 2019 · 132 citations · Full text

Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM

Dhaval Varshney, Alain‐Pierre Petit, Juan A. Bueren‐Calabuig et al. · Nucleic Acids Research · 2016 · 80 citations · Full text

, , +18

Molecular pharmacology and antitumor activity of Zalypsis® in several human cancer cell lines

Juan Fernando Martínez-Leal, Verónica García-Hernández, Victoria Moneo et al. · Biochemical Pharmacology · 2009 · 68 citations · Full text

, , +9

Temperature-induced melting of double-stranded DNA in the absence and presence of covalently bonded antitumour drugs: insight from molecular dynamics simulations

Juan A. Bueren‐Calabuig, Christophe Giraudon, Carlos M. Galmarini et al. · Nucleic Acids Research · 2011 · 65 citations · Full text

Rows per page

1–5 of 15